FI930976L - Mot tumoer riktande foerfarande och aemne - Google Patents

Mot tumoer riktande foerfarande och aemne Download PDF

Info

Publication number
FI930976L
FI930976L FI930976A FI930976A FI930976L FI 930976 L FI930976 L FI 930976L FI 930976 A FI930976 A FI 930976A FI 930976 A FI930976 A FI 930976A FI 930976 L FI930976 L FI 930976L
Authority
FI
Finland
Prior art keywords
tumoer
riktande
aemne
mot
foerfarande och
Prior art date
Application number
FI930976A
Other languages
English (en)
Finnish (fi)
Other versions
FI930976A0 (fi
FI930976A7 (fi
Inventor
Kohji Egawa
Ichiei Sato
Original Assignee
Bio Defence Inst Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Defence Inst Co Ltd filed Critical Bio Defence Inst Co Ltd
Publication of FI930976A0 publication Critical patent/FI930976A0/fi
Publication of FI930976L publication Critical patent/FI930976L/fi
Publication of FI930976A7 publication Critical patent/FI930976A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI930976A 1992-03-05 1993-03-04 Kasvaintenvastainen menetelmä ja aine FI930976A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4048840A JPH05246889A (ja) 1992-03-05 1992-03-05 制癌方法および制癌剤

Publications (3)

Publication Number Publication Date
FI930976A0 FI930976A0 (fi) 1993-03-04
FI930976L true FI930976L (fi) 1993-09-06
FI930976A7 FI930976A7 (fi) 1993-09-06

Family

ID=12814449

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930976A FI930976A7 (fi) 1992-03-05 1993-03-04 Kasvaintenvastainen menetelmä ja aine

Country Status (15)

Country Link
EP (1) EP0563627A2 (cs)
JP (1) JPH05246889A (cs)
KR (1) KR930019225A (cs)
CN (1) CN1079400A (cs)
AU (1) AU3398793A (cs)
BR (1) BR9300764A (cs)
CA (1) CA2090957A1 (cs)
CZ (1) CZ34293A3 (cs)
FI (1) FI930976A7 (cs)
HU (1) HUT67859A (cs)
IL (1) IL104944A0 (cs)
NO (1) NO930798L (cs)
NZ (1) NZ247057A (cs)
SK (1) SK15993A3 (cs)
ZA (1) ZA931558B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
IT1274592B (it) * 1994-08-05 1997-07-18 Angela Turiano Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
UY24367A1 (es) * 1995-11-23 2000-10-31 Boehringer Ingelheim Int Vacunas contra tumores y procedimiento para su produccion
EP0937258A2 (en) * 1996-10-29 1999-08-25 Fred Hutchinson Cancer Research Center, Inc. Cell stress regulated human mhc class i gene
CA2321222A1 (fr) * 1998-02-20 1999-08-26 Commissariat A L'energie Atomique Methode de selection de tumeurs exprimant hla-g, sensibles a un traitement anticancereux et ses applications
FR2775189B1 (fr) * 1998-07-24 2001-06-08 Commissariat Energie Atomique Compositions anti-tumorales a base d'antigenes hla-g ou d'anticorps anti-hla-g
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
EP1245675A1 (en) * 2001-03-28 2002-10-02 Kohji Egawa Cancer cell-specific HLA-F antigen and a diagnostic method of cancer by using thereof
CA2518237A1 (en) * 2003-03-04 2004-09-16 Greenville Hospital System Antitumor agents comprising a targeting portion and an immune response triggering portion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung

Also Published As

Publication number Publication date
JPH05246889A (ja) 1993-09-24
CA2090957A1 (en) 1993-09-06
NO930798L (no) 1993-09-06
EP0563627A2 (en) 1993-10-06
BR9300764A (pt) 1993-09-28
CN1079400A (zh) 1993-12-15
KR930019225A (ko) 1993-10-18
FI930976A0 (fi) 1993-03-04
ZA931558B (en) 1993-09-27
IL104944A0 (en) 1993-07-08
HU9300612D0 (en) 1993-05-28
AU3398793A (en) 1993-09-09
HUT67859A (en) 1995-03-23
EP0563627A3 (cs) 1994-04-27
FI930976A7 (fi) 1993-09-06
NZ247057A (en) 1995-10-26
SK15993A3 (en) 1993-10-06
CZ34293A3 (en) 1994-01-19
NO930798D0 (no) 1993-03-04

Similar Documents

Publication Publication Date Title
FI931458A7 (fi) Pyrimidinderivat och foerfarande foer deras framstaellning
FI934144L (fi) Morfinanderivat och medicinsk anvaendning
FI930605L (fi) Cd40cr-receptor och ligander foer denna
FI930064A7 (fi) Anpassningsbar ekvalisator och mottagare
FI931183A0 (fi) Halvledarkondensator och mikrofonanordning
FI930459L (fi) Schampokompositioner och suspenderingsmedel foer dessa
FI933106L (fi) Miljoevaenliga vattenbaserade nyanseringskoncentrat foer maolfaerger och dylikt
FI934243A7 (fi) Vaermeisolerande stoed foer betongvaegg och betongvaegg anvaendande detsamma
FI931085A0 (fi) Antitumoerkompositioner och behandlingsmetoder
FI924060A7 (fi) Cellulaert radionaet och mobilradiostation
FI933194L (fi) Verktyg och verktygshaollare foer handverktygsanordning
FI931675A7 (fi) Vaordshampookomposition och foerfarande foer framstaellning och anvaendningav densamma
FI930076L (fi) Cysteamin innehaollande permanentningskomposition och foerfarande
FI930831A7 (fi) Kelatkomplex och foerfarande foer deras framstaellning
FI930457L (fi) Stabilt vaordschampo innehaollande katjoniska och suspenderade vattenoloesliga vaordmedel
FI922004L (fi) Maetningsfoerfarande och maetanordning
FI932992L (fi) Fungisida fenylbenzamider och foerfaranden foer framstaellning daerav
FI930104A0 (fi) Verktyg foer slagborrning och meissling och verktygshaollare foer saodana verktyg
FI930777A7 (fi) Foeraedling och foerfarande foer avfallspapper
FI934856A0 (fi) Bandkassett och automatisk anordning foer vaermefogbara bandstycken
FI934747L (fi) a-fosfonosulfonatskvalensyntetas-inhibitorer och foerfarande
FI931346L (fi) Butadienderivat och foerfarande foer deras framstaellning
FI932801L (fi) Polyolefinfyllmedelkompositmaterialier och deras anvaendning
FI930453L (fi) Tumoerhaemmande kompositioner och behandlingsmetoder
FI925364L (fi) Foerfarande och anordning foer traodloes informationsoeverfoering